Application In Synthesis of 3,4-Dimethoxybenzaldehyde. Welcome to talk about 120-14-9, If you have any questions, you can contact Roy, T; Boateng, ST; Banang-Mbeumi, S; Singh, PK; Basnet, P; Chamcheu, RCN; Ladu, F; Chauvin, I; Spiegelman, VS; Hill, RA; Kousoulas, KG; Nagalo, BM; Walker, AL; Fotie, J; Murru, S; Sechi, M; Chamcheu, JC or send Email.
Application In Synthesis of 3,4-Dimethoxybenzaldehyde. Authors Roy, T; Boateng, ST; Banang-Mbeumi, S; Singh, PK; Basnet, P; Chamcheu, RCN; Ladu, F; Chauvin, I; Spiegelman, VS; Hill, RA; Kousoulas, KG; Nagalo, BM; Walker, AL; Fotie, J; Murru, S; Sechi, M; Chamcheu, JC in ACADEMIC PRESS INC ELSEVIER SCIENCE published article about in [Roy, Tithi; Boateng, Samuel T.; Banang-Mbeumi, Sergette; Basnet, Pratik; Chamcheu, Roxane-Cherille N.; Hill, Ronald A.; Chamcheu, Jean Christopher] Univ Louisiana, Coll Pharm, Sch Basic Pharmaceut & Toxicol Sci, 1800 Bienville Dr,Room 362, Monroe, LA 71209 USA; [Walker, Anthony L.] Univ Louisiana, Coll Pharm, Sch Clin Sci, Monroe, LA 71209 USA; [Basnet, Pratik; Chauvin, Isabel; Murru, Siva] Univ Louisiana, Dept Chem, Monroe, LA 71209 USA; [Singh, Pankaj K.; Ladu, Federico; Sechi, Mario] Univ Sassari, Dept Chem & Pharm, Via Vienna 2, I-07100 Sassari, Italy; [Spiegelman, Vladimir S.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pediat,Div Pediat Hematol Oncol, Hershey, PA 17033 USA; [Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA; [Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Nagalo, Bolni Marius] Mayo Clin Hosp, Div Hematol & Med Oncol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Fotie, Jean] Southeastern Louisiana Univ, SELU, Dept Chem & Phys, Hammond, LA 70402 USA; [Banang-Mbeumi, Sergette] Louisiana Delta Community Coll, Sch Nursing & Allied Hlth Sci, Monroe, LA 71203 USA in 2021.0, Cited 96.0. The Name is 3,4-Dimethoxybenzaldehyde. Through research, I have a further understanding and discovery of 120-14-9
Due to hurdles, including resistance, adverse effects, and poor bioavailability, among others linked with existing therapies, there is an urgent unmet need to devise new, safe, and more effective treatment modalities for skin cancers. Herein, a series of flavonol-based derivatives of fisetin, a plant-based flavonoid identified as an antitumorigenic agent targeting the mammalian targets of rapamycin (mTOR)-regulated pathways, were synthesized and fully characterized. New potential inhibitors of receptor tyrosine kinases (c-KITs), cyclin-dependent kinase-2 (CDK2), and mTOR, representing attractive therapeutic targets for melanoma and non-melanoma skin cancers (NMSCs) treatment, were identified using inverse-docking, in vitro kinase activity and various cell-based anticancer screening assays. Eleven compounds exhibited significant inhibitory activities greater than the parent molecule against four human skin cancer cell lines, including melanoma (A375 and SK-Mel-28) and NMSCs (A431 and UWBCC1), with IC50 values ranging from 0.12 to < 15 mu M. Seven compounds were identified as potentially potent single, dual or multi-kinase c-KITs, CDK2, and mTOR kinase inhibitors after inverse-docking and screening against twelve known cancer targets, followed by kinase activity profiling. Moreover, the potent compound F20, and the multi-kinase F9 and F17 targeted compounds, markedly decreased scratch wound closure, colony formation, and heightened expression levels of key cancer-promoting pathway molecular targets c-Kit, CDK2, and mTOR. In addition, these compounds downregulated Bcl-2 levels and upregulated Bax and cleaved caspase-3/7/8 and PARP levels, thus inducing apoptosis of A375 and A431 cells in a dose-dependent manner. Overall, compounds F20, F9 and F17, were identified as promising c-Kit, CDK2 and mTOR inhibitors, worthy of further investigation as therapeutics, or as adjuvants to standard therapies for the control of melanoma and NMSCs.
Application In Synthesis of 3,4-Dimethoxybenzaldehyde. Welcome to talk about 120-14-9, If you have any questions, you can contact Roy, T; Boateng, ST; Banang-Mbeumi, S; Singh, PK; Basnet, P; Chamcheu, RCN; Ladu, F; Chauvin, I; Spiegelman, VS; Hill, RA; Kousoulas, KG; Nagalo, BM; Walker, AL; Fotie, J; Murru, S; Sechi, M; Chamcheu, JC or send Email.
Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
,Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles